CAR T cells are genetically-altered cells that are designed to reset the immune system by targeting B cells, which are involved in the production of autoantibodies and lupus disease activity.
Please provide your email address to receive an email when new articles are posted on . A “complete eradication” of B cells with chimeric antigen receptor T-cell therapy is responsible for the ...
Pharmaceutical Technology on MSN
UK-developed leukaemia cell therapy to be offered on NHS
"UK-developed leukaemia cell therapy to be offered on NHS" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback